1. Home
  2. TENX vs SCOR Comparison

TENX vs SCOR Comparison

Compare TENX & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • SCOR
  • Stock Information
  • Founded
  • TENX 1967
  • SCOR 1999
  • Country
  • TENX United States
  • SCOR United States
  • Employees
  • TENX N/A
  • SCOR N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • SCOR Business Services
  • Sector
  • TENX Health Care
  • SCOR Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • SCOR Nasdaq
  • Market Cap
  • TENX 21.6M
  • SCOR 25.6M
  • IPO Year
  • TENX N/A
  • SCOR 2007
  • Fundamental
  • Price
  • TENX $6.06
  • SCOR $5.09
  • Analyst Decision
  • TENX Strong Buy
  • SCOR Buy
  • Analyst Count
  • TENX 3
  • SCOR 2
  • Target Price
  • TENX $16.00
  • SCOR $10.75
  • AVG Volume (30 Days)
  • TENX 11.9K
  • SCOR 10.9K
  • Earning Date
  • TENX 05-14-2025
  • SCOR 08-05-2025
  • Dividend Yield
  • TENX N/A
  • SCOR N/A
  • EPS Growth
  • TENX N/A
  • SCOR N/A
  • EPS
  • TENX N/A
  • SCOR N/A
  • Revenue
  • TENX N/A
  • SCOR $354,961,000.00
  • Revenue This Year
  • TENX N/A
  • SCOR $4.17
  • Revenue Next Year
  • TENX N/A
  • SCOR $2.74
  • P/E Ratio
  • TENX N/A
  • SCOR N/A
  • Revenue Growth
  • TENX N/A
  • SCOR N/A
  • 52 Week Low
  • TENX $2.77
  • SCOR $4.47
  • 52 Week High
  • TENX $7.89
  • SCOR $15.69
  • Technical
  • Relative Strength Index (RSI)
  • TENX 55.80
  • SCOR 51.46
  • Support Level
  • TENX $5.60
  • SCOR $4.47
  • Resistance Level
  • TENX $6.31
  • SCOR $5.38
  • Average True Range (ATR)
  • TENX 0.27
  • SCOR 0.31
  • MACD
  • TENX -0.01
  • SCOR 0.07
  • Stochastic Oscillator
  • TENX 63.31
  • SCOR 68.13

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.

Share on Social Networks: